// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

6 Month Outcomes of Transcatheter Annular Reduction Therapy (TART) with the ARTO™ System for Functional Mitral Regurgitation

Stephen G. Worthley - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral valve regurgitation

N/A

Effect of ABSORB bioresorbable vascular scaffold thrombosis on mortality and myocardial infarction: a systematic review and meta-analysis

Omar Meelu - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Myocardial infarction

N/A

Management and Outcomes of Angiographically Documented Stent Thrombosis

Daniel Jeffery - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Myocardial infarction

N/A

Cost utility analysis of complete versus culprit-vessel only percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction in patients with multi-vessel disease

Daniel Jones - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Individualizing DAPT Duration after Coronary Stenting for Patients at High Bleeding Risk – The LEADERS FREE trade-off score

Philip Urban - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Myocardial infarction

Biolimus A9

Predictors of advanced conduction disturbances requiring a late (≥48 hours) permanent pacemaker following transcatheter aortic valve implantation

Antonio Mangieri - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Alirocumab efficacy and safety in patients with prior coronary revascularization

Dean Kereiakes - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alirocumab

Focused Balloon Pulmonary Angioplasty for Truly Non-surgical Chronic Thromboembolic Pulmonary Hypertension – the UK experience

Stephen Hoole - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic thromboembolic pulmonary hypertension

N/A

Operator volume is not associated with mortality following Percutaneous Coronary Intervention: insights from the British Cardiovascular Intervention Society registry

William Hulme - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical outcomes of chronic total occlusion percutaneous coronary intervention - a 5 year experience in a non-surgical centre

Eunice Onwordi - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Impact of Mitral Annular Calcification on Clinical Outcomes after Transcatheter Aortic Valve Implantation

Marco Ancona - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral annular calcification

N/A

Impact of embolic protection and repositioning on stroke in patients treated with a repositionable and fully retrievable aortic valve in routine clinical practice: An analysis from the RESPOND post-market study

Jochen Wohrle - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

The Effect of Appropriate Implant Position for the Evolut R Self-Expanding Transcatheter Aortic Valve: Analysis from the FORWARD Study

Ganesh Manoharan - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Initial Experience of the Medtronic 34mm Evolut R Valve: The UK & Ireland Implanters’ Registry

Cameron Dowling - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of Clinical Judgement on Risk Stratification of Patients at High Risk for TAVR: A BRAVO-3 Subgroup Analysis

Matias Yudi - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Association Between HsTrop and Tachyarrhythmias: Type 1 or Type 2 MI? The STRIPE-MI Study

Mark Mariathas - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Down-regulation of DNA Binding Protein 1 Gene Expression Correlates With Higher Lipid Arc in Stable Angina Patients With Atherosclerosis

Nikunj Shah - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

N/A

Treating LAD Disease with a Long Stent may be Associated with Increased Cardiac Mortality Independent of Other Ischemic Events

Akiko Fujino - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Dyslipidemia

N/A

The Prognostic Value of Residual Coronary Stenosis After “Functionally” Complete Revascularization in Acute Coronary Syndrome: Insights from the DANAMI-3-PRIMULTI, FAME, and FAMOUS-NSTEMI

Yuhei Kobayashi - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Diagnostic Performance of Resting Distal to Aortic Coronary Pressure Using Instantaneous Wave-Free Ratio as a Reference Standard

Yuhei Kobayashi - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Adenosine

Copyright © 2026. QuantiNova All rights reserved